Difference between revisions of "Team:UCopenhagen"

Line 167: Line 167:
 
                     <h2 class="section-heading">Incell: a platform for synthetic endosymbiosis</h2>
 
                     <h2 class="section-heading">Incell: a platform for synthetic endosymbiosis</h2>
 
                     <p class="lead">Incell is a new synthetic biology platform with near future applications in research, industry and services. We are rewriting nature’s code for endosymbiosis and transforming an evolutionary phenomenon into a technology compatible with standard biological parts.
 
                     <p class="lead">Incell is a new synthetic biology platform with near future applications in research, industry and services. We are rewriting nature’s code for endosymbiosis and transforming an evolutionary phenomenon into a technology compatible with standard biological parts.
 
+
<br> <br>
 
Our vision is to produce synthetic host–endosymbiont systems. We set out with a trinity of experiments intrinsic to the synthetic reconstruction of endosymbiosis. First, creating and sustaining dependence between a host and its endosymbionts by fulfilling the amino acid requirement of an auxotrophic host. Next, to build a modular system of cell-penetrating peptides for protein transport of host nuclear encoded proteins into an endosymbiont, recapitulating a crucial feature of the natural process. Finally, regulating the number of endosymbionts within a host using a CRISPR-Cas system for control of replication.
 
Our vision is to produce synthetic host–endosymbiont systems. We set out with a trinity of experiments intrinsic to the synthetic reconstruction of endosymbiosis. First, creating and sustaining dependence between a host and its endosymbionts by fulfilling the amino acid requirement of an auxotrophic host. Next, to build a modular system of cell-penetrating peptides for protein transport of host nuclear encoded proteins into an endosymbiont, recapitulating a crucial feature of the natural process. Finally, regulating the number of endosymbionts within a host using a CRISPR-Cas system for control of replication.
 
+
<br> <br>
 
Further ahead we see a safe, customisable, sustainable technology providing biological solutions to present and future challenges in biotechnology, agriculture and medicine.
 
Further ahead we see a safe, customisable, sustainable technology providing biological solutions to present and future challenges in biotechnology, agriculture and medicine.
  
 
                     <br> <br>
 
                     <br> <br>
                     På denne side kan du også finde information omkring kampe og turneringer, hvilke arrangementer vi tilbyder samt vores sociale medieprofiler.</p>
+
                     </p>
 
                 </div>
 
                 </div>
 
                 <div class="col-lg-5 col-lg-offset-2 col-sm-6">
 
                 <div class="col-lg-5 col-lg-offset-2 col-sm-6">

Revision as of 15:48, 8 September 2017


<!DOCTYPE HTML> inCell